CSO

Geek+ and System Teknik deploy first PopPick solution in the Nordics for the pharmacy group Med24.dk

Retrieved on: 
Wednesday, April 24, 2024
Health, Pharmacy, Peter Hancock (professor), CSO, Warehouse

System Teknik partnered on the Denmark project, which includes three PopPick stations and 30 Shelf-to-Person robots, bringing a flexible solution to a region where fixed automation still dominates.

Key Points: 
  • System Teknik partnered on the Denmark project, which includes three PopPick stations and 30 Shelf-to-Person robots, bringing a flexible solution to a region where fixed automation still dominates.
  • Peak season events had also caused considerable strain to their operations," said Blond Shkodrani, channel partner manager for the Nordics at Geekplus.
  • "Due to their overwhelming success, Med24.dk needed a modular, automated order fulfillment solution for fast, efficient order fulfillment."
  • "Through trusted partners like System Teknik, we're showing customers all over Europe that Geekplus truly is a one-stop shop for modular warehouse automation," Shkodrani said.

New York-Based AgentSmyth Launches Autonomous AI Agents for the Finance Sector, Raises $2.5M in Seed Funding from Industry Veterans

Retrieved on: 
Wednesday, April 17, 2024
A.I, BAML, AI, Comprehension, LLM, Daniel, Entrepreneurship, Wall, CSO, Multimedia

NEW YORK, April 17, 2024 /PRNewswire-PRWeb/ -- AgentSmyth, a leading agent technology firm located in New York, recently introduced an innovative advancement in the financial sector with its autonomous AI agents. Founded in March 2024 by a skilled team comprising serial entrepreneur and technologist Pulkit Jaiswal, and Wall Street veterans Daniel McCooey and Mike Block, AgentSmyth is now a major player in financial-sector automation technology. The company's foundation is strengthened by its founders' expertise in various fields, including buy and sell-side equity trading, venture capital, and the application of agent-based LLM methodologies to comprehensive financial data sets. In a short time, AgentSmyth has attracted significant support, securing $2.5 million in seed funding from notable industry experts like Michael Rafferty, CEO of Rafferty Holdings and investor in fintech companies, and Craig Milias, former portfolio manager of Platte River Capital. This funding reflects the financial sector's confidence in AgentSmyth's innovative approach to AI-driven financial analysis and decision-making.

Key Points: 
  • With $2.5 million in seed funding, the company utilizes expertise in equity trading and LLM methodologies to offer advanced decision-making tools.
  • These AI agents are designed to revolutionize financial-sector automation, positioning AgentSmyth as a potential leader in the industry.
  • AgentSmyth stands out by creating smart autonomous agents that act as specialized team members, revolutionizing coordination in finance.
  • As the pioneering provider of end-to-end autonomous agents in finance, AgentSmyth is on track to become a global leader in financial analysis.

CISOs Connect's Board of Distinguished CISOs Selects Top 100 Peers, Honoring Professional Prowess and Contributions to Industry

Retrieved on: 
Tuesday, April 16, 2024
C100, Telecommunications, Organization, Mentorship, CISO, Synchrony, Rest, Culture, SVP, Colin Anderson, Black kite, CSO, H.I.G. Capital, GSR, Management

NEW YORK, April 16, 2024 /PRNewswire/ -- CISOs Connect's™ Esteemed Board of Judges has announced this year's winners of its preeminent peer-to-peer tribute, the CISOs Connect's™ Top 100 CISOs (C100) awards.

Key Points: 
  • NEW YORK, April 16, 2024 /PRNewswire/ -- CISOs Connect's™ Esteemed Board of Judges has announced this year's winners of its preeminent peer-to-peer tribute, the CISOs Connect's™ Top 100 CISOs (C100) awards.
  • What distinguishes these awards from other industry honors is the transparency of the process, with defined eligibility criteria and a declared board of judges to choose the winners.
  • We created the C100 to recognize those who take it a step further through continuous learning and impressive contributions to the industry."
  • In addition to honoring the Top 100 CISOs in the U.S., the Board of Esteemed Judges also paid tribute to four other peers.

GeneVentiv Therapeutics Awarded $2.5 Million SBIR Grant to Advance Gene Therapy for All Hemophilias, with or without Inhibitors

Retrieved on: 
Tuesday, April 16, 2024
Haemophilia, Bangladesh Technical Education Board, Mouse, NIH, NHLBI, IND, Patient, CSO, SBIR, Therapy, Pharmaceutical industry

RALEIGH, N.C., April 16, 2024 /PRNewswire/ -- GeneVentiv Therapeutics, developer of GENV-HEM (AAV8.FVa) for all hemophilias, announced today it has been awarded a Direct to Phase II Small Business Innovation Research (SBIR) grant for approximately $2,500,000 from the National Heart Lung Blood Institute (NHLBI) at the National Institutes of Health (NIH). The award for "Development of a universal gene therapy for hemophilia A or B with or without inhibitors" enables a large animal study and assay development to support IND-enabling biodistribution and toxicology studies.

Key Points: 
  • The award for "Development of a universal gene therapy for hemophilia A or B with or without inhibitors" enables a large animal study and assay development to support IND-enabling biodistribution and toxicology studies.
  • "GENV-HEM successfully treats hemophilia A or B with or without inhibitors in mice.
  • The grant also supports assay development for an IND-enabling biodistribution and toxicology study to be funded by our Series A," commented Paris Margaritis, CSO of GeneVentiv Therapeutics.
  • "GENV-HEM has the potential for lifetime treatment of hemophilia patients with or without inhibitors with a single infusion.

Averatek Relaunches as LQDX.com - Raises $10M in Equity & Government Funding

Retrieved on: 
Monday, April 15, 2024
AI, Business development, Semblant, Artificial intelligence, Artificiality, AT&S, Lam Research, CSO, Applied Materials, Apple, Inotera, Growth, Management

SANTA CLARA, Calif., April 15, 2024 /PRNewswire/ -- Averatek Corp., developer of high-performance materials for advanced semiconductor manufacturing, today announced that it has relaunched as LQDX ('lik-WID-ix) to focus on the rapid adoption of its Artificial Intelligence enabling chemistries and process technologies. To fund this next stage of growth, the company has concluded a combined equity and initial government funding round of $10M USD.

Key Points: 
  • To fund this next stage of growth, the company has concluded a combined equity and initial government funding round of $10M USD.
  • The refocus enables us to build our team and support systems for the next phase of growth as an advanced chemical and process licensing business."
  • "There has never been a time like this in the semiconductor industry," said Scott Meikle, Chairman.
  • "LQDX has reengineered every element of the company to prepare ourselves and our partners for the unprecedented ramp in advanced interconnect technology and chiplet-driven architecture."

Conversant Group Executive to Speak at ILTA Evolve

Retrieved on: 
Thursday, April 11, 2024
Intelligence, Smith, Sheraton, EVOLVE, CSO

CHATTANOOGA, Tenn., April 11, 2024 /PRNewswire/ -- Conversant Group™, an innovative provider of "Secure First" infrastructure and cybersecurity services, announced today that its company founder and CSO, John Anthony Smith, will present on the topic "Top 15 Security Actions Firms Should Take to Defend Against New Threats" at ILTA Evolve 2024.

Key Points: 
  • CHATTANOOGA, Tenn., April 11, 2024 /PRNewswire/ -- Conversant Group ™, an innovative provider of "Secure First" infrastructure and cybersecurity services, announced today that its company founder and CSO, John Anthony Smith, will present on the topic "Top 15 Security Actions Firms Should Take to Defend Against New Threats" at ILTA Evolve 2024.
  • EVOLVE will focus on the two most pressing issues in legal tech and will spotlight the latest trends in technology.
  • 2024 ILTA EVOLVE is all about generative artificial intelligence and cybersecurity.
  • For more information about ILTA Evolve 2024 and John Anthony Smith's presentation, visit the event site .

Ginkgo Bioworks Previews Today's Annual Ferment Conference, Announces "Lab Data as a Service"

Retrieved on: 
Thursday, April 11, 2024
Health policy, School, Agriculture, Executive, Shoe, Fermentation, Flagship Pioneering, College of Engineering (KNUST), Public health, Practice, Foundry, AI, Protein engineering, Research, Radar, Systems biology, Doctor of Philosophy, Creative, Response, Corporate development, DNA, Novo Nordisk, SVP, Senior, Pandemic, New Yorker, Synthetic biology, MIT Media Lab, Intelligence cycle, CSO, Harvard Medical School, Biology, Carbon sequestration, Nitrogen fixation, Senior advisor, Concentric objects, Engineering, Management

BOSTON, April 11, 2024 /PRNewswire/ -- Today, Ginkgo Bioworks (NYSE: DNA ), which is building the leading platform for cell programming and biosecurity, is hosting its 5th annual Ferment conference.

Key Points: 
  • BOSTON, April 11, 2024 /PRNewswire/ -- Today, Ginkgo Bioworks (NYSE: DNA ), which is building the leading platform for cell programming and biosecurity, is hosting its 5th annual Ferment conference.
  • Jason Kelly, CEO and co-founder, Ginkgo Bioworks: "AI is rapidly changing how all of us think about biological research.
  • Matt McKnight, General Manager of Biosecurity, Ginkgo Bioworks: "I'm so excited to share our keystone products with the world today.
  • Barry Canton, CTO and co-founder, Ginkgo Bioworks: "Data is the limiting reagent for AI.

Corero Network Security Enters New Relationship with TierPoint

Retrieved on: 
Thursday, April 11, 2024
CNS, OTC, AIM, Partnership, Trust, CSO, Arms industry

MARLBOROUGH, Mass., April 11, 2024 /PRNewswire/ -- Today, Corero Network Security (AIM: CNS, OTC: DDOSF), the distributed denial of service (DDoS) protection specialists, announces its new partnership with TierPoint.

Key Points: 
  • MARLBOROUGH, Mass., April 11, 2024 /PRNewswire/ -- Today, Corero Network Security (AIM: CNS, OTC: DDOSF), the distributed denial of service (DDoS) protection specialists, announces its new partnership with TierPoint.
  • TierPoint has selected Corero Network Security for its next-generation DDoS defense infrastructure, underlining the critical need for cutting-edge, reliable cyber defense mechanisms in today's digital landscape.
  • Carl Herberger, CEO of Corero Network Security, expressed his enthusiasm about the new partnership, stating, "We are thrilled to welcome TierPoint to the Corero family.
  • The relationship with TierPoint signifies Corero's continued momentum in the cyber security space, further establishing its position as a preferred provider of innovative DDoS protection solutions for enterprises worldwide.

Biomica to Present at Digestive Disease Week (DDW) Conference 2024 Annual Meeting

Retrieved on: 
Thursday, April 11, 2024
Irritable bowel syndrome, University, System, UNC, Research, NYU, Entrepreneurship, Visceral pain, Therapy, Patient, CSO, DDW, Annual general meeting, Abdominal pain, IBS, Pharmaceutical industry

REHOVOT, Israel, April 11, 2024 /PRNewswire/ -- Biomica Ltd., a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd. (Nasdaq: EVGN, TASE: EVGN), today announced that it will present results from pre-clinical studies in its irritable bowel syndrome (IBS) program at the Digestive Disease Week (DDW) 2024 Annual Meeting.

Key Points: 
  • REHOVOT, Israel, April 11, 2024 /PRNewswire/ -- Biomica Ltd., a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd. (Nasdaq: EVGN, TASE: EVGN), today announced that it will present results from pre-clinical studies in its irritable bowel syndrome (IBS) program at the Digestive Disease Week (DDW) 2024 Annual Meeting.
  • The conference is being held in Washington, D.C., May 18-21, 2024.
  • The pre-clinical work was led by Prof. Yehuda Ringel, Biomica's Co-Founder and CSO, in collaboration with the lab of Prof. Kara Gross Margolis, at the NYU Grossman School of Medicine.
  • In the studies, Biomica tested two candidate therapeutic consortia of live bacterial strains, BMC426 and BMC427.

KATIE BARR JOINS WORKSTORM EXECUTIVE TEAM, HIGHLIGHTING FOCUS ON LEGAL INDUSTRY

Retrieved on: 
Wednesday, April 10, 2024
Knowledge, Thought, Pressure, Privacy, CSO, Growth, AI

As CSO, Barr is responsible for driving the commercial strategy of Workstorm, and steering initiatives for sustainable growth and market presence.

Key Points: 
  • As CSO, Barr is responsible for driving the commercial strategy of Workstorm, and steering initiatives for sustainable growth and market presence.
  • Workstorm Co-Founder and CEO Raj Fernando stated, "Katie has unique expertise in enterprise software strategy, notably in the Fortune 100 and legal sector.
  • "Technology is a constantly evolving industry and AI is putting even more pressure on protecting privacy and data," said Barr.
  • With close to twenty years of experience in the enterprise software sector, Barr brings to Workstorm a wealth of knowledge and expertise with a specific focus on the legal industry.